CHRISTOPHER GUZIK: Open Payments
NPI 1396762126 · CLERMONT, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$607 in 31 payments from 16 companies in 2025. Trend: 2023 $367 · 2024 $650 · 2025 $607
Food & beverage: $607
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $103 |
| GlaxoSmithKline, LLC. | 3 | $63 |
| Amgen Inc. | 3 | $56 |
| Exact Sciences Corporation | 2 | $48 |
| Merck Sharp & Dohme LLC | 2 | $43 |
| Abbott Laboratories | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| PFIZER INC. | 2 | $39 |
| SANOFI PASTEUR INC. | 2 | $32 |
| Lilly USA, LLC | 2 | $30 |
Products named: Ozempic, Cologuard Collection Kit, TRELEGY ELLIPTA, CAPVAXIVE, OTEZLA, FREESTYLE LIBRE 3, PREVNAR 20, Wegovy.
Industry payments across FL — which companies pay providers there.
